EXO1/P53/SREBP1 Axis-Regulated Lipid Metabolism Promotes Prostate Cancer Progression

Scientists discovered that EXO1 acted as a novel biomarker of prostate cancer, which promoted prostate cancer progression by regulating lipid metabolism reprogramming in prostate cancer cells.